4-92590245-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001510.4(GRID2):c.203C>T(p.Thr68Met) variant causes a missense change. The variant allele was found at a frequency of 0.0424 in 1,612,220 control chromosomes in the GnomAD database, including 1,615 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001510.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRID2 | ENST00000282020.9 | c.203C>T | p.Thr68Met | missense_variant | 2/16 | 1 | NM_001510.4 | ENSP00000282020.4 | ||
GRID2 | ENST00000510992.5 | c.203C>T | p.Thr68Met | missense_variant | 2/15 | 1 | ENSP00000421257.1 | |||
GRID2 | ENST00000505687.5 | n.375C>T | non_coding_transcript_exon_variant | 2/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0359 AC: 5458AN: 152044Hom.: 116 Cov.: 32
GnomAD3 exomes AF: 0.0355 AC: 8907AN: 251148Hom.: 204 AF XY: 0.0365 AC XY: 4952AN XY: 135724
GnomAD4 exome AF: 0.0431 AC: 62857AN: 1460058Hom.: 1498 Cov.: 30 AF XY: 0.0424 AC XY: 30806AN XY: 726370
GnomAD4 genome AF: 0.0359 AC: 5461AN: 152162Hom.: 117 Cov.: 32 AF XY: 0.0348 AC XY: 2589AN XY: 74380
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2022 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GRID2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at